# Understanding the Novo Nordisk CEO’s defense of Ozempic price in Senate testimony – Novo Nordisk CEO, Lars Fruergaard Jorgensen, defended the price of Ozempic in a Senate testimony. – Jorgensen emphasized the importance of innovation in the pharmaceutical industry to improve patient outcomes. – He explained that the pricing of Ozempic reflects the value it brings to patients and the healthcare system. – The CEO highlighted the investment in research and development that goes into bringing new and effective treatments to market. Novo Nordisk CEO, Lars Fruergaard Jorgensen, recently defended the price of Ozempic in a Senate testimony, reiterating the company’s commitment to innovation in the pharmaceutical industry. Jorgensen emphasized the value that Ozempic brings to patients and the healthcare system, emphasizing the investment in research and development that goes into developing new treatments. This testimony sheds light on the company’s dedication to improving patient outcomes through cutting-edge therapies. If you are considering Ozempic for weight loss or diabetes management, reach out to Mindful Evolution for personalized support and guidance through telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. *Weight loss disclaimer: Individual results may vary. Consult with a healthcare provider before starting any weight loss program.*